Board of Directors

Rich Ganz, MBA

Executive Chairman

Brian Miller, MS, MBA

CEO and Co-Founder

Biju Parekkadan, PhD

Scientific Co-Founder and Scientific Advisory Board

Kanad Das, PhD

Investment Director, Boehringer Ingelheim Venture Fund

Johannes Fruehauf, MD, PhD

Co-Founder and General Partner, BioInnovation Capital

Giacomo Chiesi, MBA

Managing Partner at Chiesi Ventures

Scientific/Clinical Advisory Board

Joseph Bonventre, MD, PhD
Chief of Renal Division and Biomedical Engineering Division, Brigham and Women’s Hospital, Harvard Medical School

Herb Lin, MD, PhD
Director of Translational Research, Division of Nephrology at Massachusetts General Hospital
Associate Professor of Medicine, Harvard Medical School

Bruce Littman, MD
CEO of EyGen, Ltd.
Former Vice President and Head of Translation, Pfizer

Biju Parekkadan, PhD
Scientific Co-Founder and Board of Directors, Sentien Biotechnologies
Associate Professor of Bioengineering and Medicine, Rutgers University
Core Faculty Member at the Center for Surgery, Innovation, and Bioengineering, Harvard Medical School

Greg Russotti, PhD
Chief Technology Officer, Century Therapeutics